As of 2025-07-10, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is 199.52 USD. This relative valuation is based on P/E multiples. With the latest stock price at 39.07 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is 410.7%.
The range of the Relative Valuation is 129.40 - 297.35 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 25.9x | 20.7x |
| Forward P/E multiples | 13.4x - 20.6x | 16.7x |
| Fair Price | 129.40 - 297.35 | 199.52 |
| Upside | 231.2% - 661.1% | 410.7% |
| Date | P/E |
| 2025-07-08 | 3.18 |
| 2025-07-07 | 3.06 |
| 2025-07-03 | 3.14 |
| 2025-07-02 | 3.07 |
| 2025-07-01 | 2.99 |
| 2025-06-30 | 2.89 |
| 2025-06-27 | 2.91 |
| 2025-06-26 | 2.93 |
| 2025-06-25 | 2.84 |
| 2025-06-24 | 2.91 |
| 2025-06-23 | 2.90 |
| 2025-06-20 | 2.99 |
| 2025-06-18 | 3.09 |
| 2025-06-17 | 3.02 |
| 2025-06-16 | 3.11 |
| 2025-06-13 | 2.98 |
| 2025-06-12 | 3.00 |
| 2025-06-11 | 2.99 |
| 2025-06-10 | 3.00 |
| 2025-06-09 | 2.93 |
| 2025-06-06 | 2.99 |
| 2025-06-05 | 2.92 |
| 2025-06-04 | 2.96 |
| 2025-06-03 | 2.90 |
| 2025-06-02 | 2.84 |
| 2025-05-30 | 2.79 |
| 2025-05-29 | 2.77 |
| 2025-05-28 | 2.68 |
| 2025-05-27 | 2.63 |
| 2025-05-23 | 2.59 |
| 2025-05-22 | 2.57 |
| 2025-05-21 | 2.62 |
| 2025-05-20 | 2.62 |
| 2025-05-19 | 2.60 |
| 2025-05-16 | 2.54 |
| 2025-05-15 | 2.46 |
| 2025-05-14 | 2.44 |
| 2025-05-13 | 2.50 |
| 2025-05-12 | 2.53 |
| 2025-05-09 | 2.38 |
| 2025-05-08 | 2.44 |
| 2025-05-07 | 2.45 |
| 2025-05-06 | 2.46 |
| 2025-05-05 | 2.61 |
| 2025-05-02 | 2.62 |
| 2025-05-01 | 2.69 |
| 2025-04-30 | 2.58 |
| 2025-04-29 | 2.53 |
| 2025-04-28 | 2.58 |
| 2025-04-25 | 2.56 |